1. Home
  2. OMCL vs KROS Comparison

OMCL vs KROS Comparison

Compare OMCL & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMCL
  • KROS
  • Stock Information
  • Founded
  • OMCL 1992
  • KROS 2015
  • Country
  • OMCL United States
  • KROS United States
  • Employees
  • OMCL N/A
  • KROS N/A
  • Industry
  • OMCL Computer Manufacturing
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • OMCL Technology
  • KROS Health Care
  • Exchange
  • OMCL Nasdaq
  • KROS Nasdaq
  • Market Cap
  • OMCL 2.0B
  • KROS 1.8B
  • IPO Year
  • OMCL 2001
  • KROS 2020
  • Fundamental
  • Price
  • OMCL $48.89
  • KROS $64.88
  • Analyst Decision
  • OMCL Buy
  • KROS Strong Buy
  • Analyst Count
  • OMCL 8
  • KROS 8
  • Target Price
  • OMCL $49.14
  • KROS $91.43
  • AVG Volume (30 Days)
  • OMCL 595.2K
  • KROS 360.6K
  • Earning Date
  • OMCL 10-30-2024
  • KROS 11-06-2024
  • Dividend Yield
  • OMCL N/A
  • KROS N/A
  • EPS Growth
  • OMCL N/A
  • KROS N/A
  • EPS
  • OMCL N/A
  • KROS N/A
  • Revenue
  • OMCL $1,064,205,999.00
  • KROS $651,000.00
  • Revenue This Year
  • OMCL N/A
  • KROS $1,232.45
  • Revenue Next Year
  • OMCL $4.97
  • KROS $126.39
  • P/E Ratio
  • OMCL N/A
  • KROS N/A
  • Revenue Growth
  • OMCL N/A
  • KROS 8037.50
  • 52 Week Low
  • OMCL $25.12
  • KROS $27.31
  • 52 Week High
  • OMCL $55.75
  • KROS $73.00
  • Technical
  • Relative Strength Index (RSI)
  • OMCL 58.06
  • KROS 59.88
  • Support Level
  • OMCL $48.21
  • KROS $65.54
  • Resistance Level
  • OMCL $53.31
  • KROS $70.26
  • Average True Range (ATR)
  • OMCL 2.53
  • KROS 2.67
  • MACD
  • OMCL 0.45
  • KROS 0.52
  • Stochastic Oscillator
  • OMCL 58.92
  • KROS 57.74

About OMCL Omnicell Inc. ($0.001 par value)

Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: